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4-Amino-, 4-oxo-, and 4-hydroxy-cyclohexane-1,1-dicarbo-
xylic acids have been inserted into di- and tri-peptides containing 
glycine, L-phenylalanine, L-cyclohexylalanine, an d L-tyrosine. The 
geometries of 4-c-(IX A) and 4-t-(IX B) benzamidocyclohexane-
-r-1-carboxy-1-carbonyl-L-phenylalanine methyl esters and 4-c-
-(XXIII A) and 4-t-(XXIII B) benzoxycyclohexane-r-1 -carbo-
methoxy-1-carbonyl-L-cyclohexylalanine methyl esters were con-
firmed by their NMR spectra and intramolecular cyclisations of 
the cis isomers. The ring opening of 2-oxabicyclo[2.2.2]octan-3-one-
-4-carbonyl-L-cyclohexylalanine methyl ester (XXIV) in metha-
nolic hydrochloric acid afforded 4-c-hydroxycyclohexane-r-1-
-carbomethoxy-1-carbonyl-L-cyclohexylalanine methyl ester (XXI 
A) which on benzoylation was converted into the product identical 
with the isomer (XXIII A) . 
The thyrotropin releasing hormone (TRH) and cert ain analogous peptides 
of low molecular weights1 •2 , appart from their endocrine functions , may have 
roles in controlling neuronal excitabilities in the central nervous system3• The 
synthesis of L-pyroglutamyl-L-histidyl-L-proline amide4,5 confirmed the struc-
ture of TRH6, isolated from ovine hypothalamic extracts7• 
We considered the possibility that low m olecular peptides, containing 
various cyclic systems8 and carbamoyl group, may increase their biological 
potencies. Thus, as has already been reported9•1o the polyfunctional L-tyrosyl-
-L-hystidyl-L-lysine (I), containing heterocyclic systems, stimulated the in-
corporation of the labelled sulphate into an embryonic chick cartilage. On the 
other hand our synthesis of diethyl 2-N-(N- t-butoxycarbonyl-r.-phenylalanyl)c-
-2-amino-r-1-carbamoylcyclohexane-5,5-dicarboxylate11 (II) by reductive ring 
opening of diethyl 4,5,6, 7-tetrahydro-3-oxo-2H-indazole-5,5-dicarboxylate12 (III) 
and coupling of the resulting aminocyclohexane dicarboxylate with the suc-
cinimide ester of N-t-butoxycarbonyl-r.-phenylalanine could be regarded as 
an example of the carbamoyl group containing peptides. 
As part of our continuing programme on the synthesis of unusual peptides 
containing cyclic systems, we decided to study the stereoisomeric 4-substituted 
cyclohexane-1,1-dicarboxylic acid peptides. To our knowledge only the stereo-
chemistry of 2-13,14 , 3-15, and 4-16,17 aminocyclohexane carboxylic acids have 
been investigated in more details, the latter being coupled with several amino 
acid derivatives. Furthermore, in a previous article18 we described cis- and 
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trans-3- and 4-amino-, hydroxymethyl-, and chloromethyl-cyclohexane-1-car-
boxylic acids inserted into di- and tri-peptides containing L-phenylalanine and 








Boc-Phe = t-butoxycarbonyl- -phenylalanine 
cyclohexane-dicarboxylic acids area. During this study it was found that the 
attachments of amino acid derivatives to the equatorial or axial C-terminus 
of 4-amino-cyclohexane-1,1-dicarboxylic acid could provide hitherto unknown 
chains and also adequate models for better understanding of their conformat-
ional features. 
In order to circumvent undesirable reactions of 4-benzamidocyclohexane-
-1, 1-dicarboxy lie acid (IV) in to 1, 3-dicyclohexy 1-2, 4, 6-trioxopyrimidine-5-spiro-
-1 ' ( 4' -benzamidocyclohexane) (V), when dicyclohexylcarbodi-imide was used 
as the condensing agent19- 22, a modified triphenyphosphine-carbon tetrachloride 
method23- 26 was shown to be the most convenient one for the synthesis of the 
stereo isomeric 4-benzamidocyclohexane-1-carboxy-1-carbony lglicine ethyl ester 
(VI). It is noteworthy that the synthesis of the peptide (VI), isolated as one of 
the two possible isomers, was completed at room temperature within 2.5 h in 
87'°/o yield, and that the prolonged time of reaction (19 h) did not facilitate the 
formation of 4-benzamidocyclohexane-1,1-dicarbonylglycine diethyl ester (VII), 





(VIl R•OH, R1=Gly0Et 
1 . (VIII R=R =GlyOEt 




r--.--f-coPheOft1 . r---+coR 
BzHN..f---.-__j BzHN..f---.-__j 
A (X) R=OH: R1=Bzl B I 
(IX) R=OH R1=M• I 
<x:l). R=OMe, R1.=Mo 
GlyOEt =glycine ethyl ester 
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4-benzamidocyclohexane-1-carbethoxy-1-carbonylglycine ethyl ester (VIII) ; its 
stereoisomeric purity was established by NMR data. 
In contrast to the isolation of only one of the two possible glycine-di peptides 
(VI) as isomer, L-phenylalanine-dipeptides, obtained from the reaction of 
dicarboxylic acid (IV) with L-phenylalanine methyl or benzyl ester, separated 
as 4-c- (IX A) and 4-t- (IX B) benzamidocyclohexane-1-carboxy-1-carbonyl-r.-
-phenylalanine methyl and benzyl (X A) and (X B) esters, respectively. The 
isomeric carboxylic acid peptides (IX A) and (IX B), formed in ratio 1.7 : 1.0, 
were esterified to the corresponding cis- (XI A) and trans- (XI B) carbomethoxy 
derivatives. The cis-geometry of (XI A) could be proved by an intramolecular 
cyclisation leading to 2-benzoyl-2-azabicyclo[2.2 .2]octan-3-one-4-carbonyl-r.-
-phenylalanine methyl ester (XII) . 
To exemplify a peptide chain elongation at the N- and C-terminus 4-oxo-
cyclohexane-1,1-dicarboxylic acid27 (XIII) was first converted into 4-oxocyclo-
hexane-1-carboxy-1-carbonyl-r.-phenylalanine methyl ester (XIV) and then 
esterified to 4-oxocyclohexane-1-carbomethoxy-1-carbony 1-L-pheny lalanine 
methyl ester (XV). The latter on oximation28, followed by hydrogenation of the 
resulting oxime (XVI) over 50/o Rh/Al20 329, gave the desired 4-aminocyclo-
hexane-1-carbomethoxy-1-carbonyl-L-phenylalanine methyl ester (XVII) cha-
racterized as N-benzoyl derivative (XVIII) . The C-dipeptide (XVII), obtained 
in high overall yield, was finally elongated at the N-terminus in a reaction 
with N-hydroxysuccinimide ester of N -t-butoxycarbony 1-0-benzyl-r.-tyrosine 
COR XO 
COR1 
(XIII) X = 0, R = R 1 = OH 
(XIV) X = 0, R = OH, R1 = PheOMe 
(XV) X = 0, R = OMe, R1 = PheOMe 




(XVII) R = H 
(XVIII) R = Bz 
(XIX) R = Boc-Tyr(OBzl) 
Boc-Tyr(OBzl) = t-butoxycarbonyl-0-benzyl-r.-tyrosyl; ChaOMe = r.-cyclohexyla-
lanine methyl ester 
g1vmg 4-N-(N-t-butoxycarbonyl-0-benzyl-L-tyrosyl) 4-aminocyclohexane-1-
-carbomethoxy-1-carbonyl-L-cyclohexylalanine methyl ester (XIX). It should be 
mentioned that the stereochemistry of these peptides remains to be solved and 
will be described in a forthcoming paper. 
The stereo isomeric 4-hydroxycyclohexane-1-carboxy-1-car bony 1-L-cyclo-
hexylalanine methyl ester (XX) and their 1-carbomethoxy derivatives (XXI) 
were prepared by the hydrogenations of 4-oxocyclohexanes (XIV) and (XV), 
respectively, over Pt02 as catalyst. A treatment of 4-oxocyclohexane-1-carbo-
methoxy peptide (XV) with sodium borohydride in anhydrous methanol, how-
ever, afforded 4-hydroxycyclohexane-1-car bomethoxy-1-carbony 1-L-pheny lala-
nine methyl esters (XXII) with preserved aromatic ring. 
In the successful separation of the stereoisomeric 4-hydroxycyclohexane-
-1,1-dicarboxylic acid peptides their benzoylations were shown to be decisive. 
Thus 4-benzoxycyclohexane-1-carbomethoxy-1-carbonyl-r.-cyclohexylalanine 
methyl esters (XXIII) were separated by preparative TLC providing cis-
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(XXIII A) and trans-(XXIII B) isomer at RF ca. 0.24 and 0.21 in 47.9 and 28.40/o 
yields, respectively. 
.!XX) R=OH, R1= ChaOMe 
(XX!l R=OMe, R1=Cha0Me 









An intramolecular cyclisation of a mixture of the stereoisomeric 4-hydroxy-
cyclohexane-1-carboxy dipeptides (XX) proceeded into 2-oxabicyclo[2.2.2]octan-
-3-one-4-carbonyl-L-cyclohexylalanine methyl ester (XXIV) in 41.8'0/o yield. 
This bicyclic product (XXIV) was unambiguously reopened by treatment with 
30/o methanolic hydrochloric acid into 4-c-hydroxycyclohexane-r-1-carbo-
methoxy-1-carbonyl-L-cyclohexylalanine methyl ester (XXI A), which on ben-
zoylation yielded the cis-isomer (XXIII A) . 
EXPERIMENTAL 
Melting points were determined on a Kofler hot-stage apparatus. The IR spectra 
were obtained for potassium bromide pellets or liquid films on a Perkin-Elmer 297 
spectrophotometer. UV spectra were taken for solutions in ethanol with a Perkin-
-Elmer 124 spectrophotometer. NMR spectra were measured for solutions in deute-
riochloroform on a Varian A60 spectrometer with tetramethylsilane as the internal 
standard for organic solutions. Mass spectra were measured with a Varian MAT CH7 
spectrometer and optical rotations in methanol (1 = 1 dm) (unless otherwise stated) 
using a Zeiss-Winkel 179707 apparatus. The silica gel (Merck 0.08 mm) which was 
used for column chromatography and (Merck HF254, type 60) for TLC and for pre-
parative TLC was activated at 110 °c for 60 min. The products were developed in 
methylene chloride - methanol (9 : 1) unless otherwise stated and rendered visible 
by u. v. illumination and by a ninhydrin spray. 
4-Benzamidocyclohexane-1,1-dicarboxylic Acid (IV) 
A solution of diethyl 4-benzamidocyclohexane-,l,ldicarboxylate (209 mg, 0.602 
mmol), obtained by benzoylation of the corresponding 4-aminocyclohexane . deriva-
tive30, was treated with 200/o methanolic potassium hydroxide (10 ml) and heated 
under reflux for 50 min. The solvent was removed, the residue diluted with water, 
and then acidified with hydrochloric acid (to pH 3) . The ethyl acetate extract afforded 
the produtc (173 mg, 98.70/o), m. p. 227-229 °c from methanol-ether-n-hexane), R1•' 
ca. 0.1. · 
Anal. C15H17NOs (291.30) calc'd.: C 61.85; H 5.88; N 4.810/o 
· found: C 61.75; H 6.15; N 5.060/o 




To a suspension of 4-benzamidocyclohexane-1,1-dicarboxylic acid (IV) (146 mg, 
0.5 mmol) in tetrahydrofurane (4 ml), cooled at 0 '°C, dicyclohexylcarbodi-imide (221 
mg, 1.1 mmol) was added and then stirred at room temperature for 3 days. A preci-
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pitate was removed by suction and the filtrate evaporated to dryness. The residue 
was chromatographed on a silica gel column. The product, Rp ca. 0.72, 410/0 (100 mg), 
m. p. 209-210 °c (from chloroform-n-hexane) . 
Anal. C2sHa1N304 (479.60) calc'd.: C 70.12; H 7.78; N 8.760/o 
found: C 70.28 ; H 7.60 ; N 8.53°/o 
Mass spectrum: m/e (M+) 479, requires 479 .60. UV spectrum: Amax 229 nm (log £ 3.99). 
IR spectrum: Yrnax 3416, 1743, 1684, 1648, 757, a nd 710 cm-1• NMR spectrum: -r 2.12-2.43 
and 2.45-2.68 (2H and 3H,2m,aromatic protons), 3.80 (lH,d,CONH; J 7.9 Hz), 5.17-6.33 
(3H,m,3CH). 
4-Benzamidocyclohexane-1-carboxyl-l-carbonylglycine Ethyl Ester (VI) 
a) A suspension of 4-benzamidocyclohexane-1,1-dicarboxylic acid (IV) (50 mg, 
0.172 mmol), hydrochloride of glycine ethyl ester (48 mg, 0.344 mmol), triphenylphos-
phine (90 mg, 0.344 mmol), triethylamine (0.072 ml, 0.514 mmol), and carbon tetra-
chloride (0.035 ml, 0.35 mmol) in acetonitrile (2 ml) was stirred at room temperature 
for 2.5 h . The solvent was removed under reduced pressure and the residue dissolved 
in ethyl acetate, washed with 50/o citric acid, and then extracted with 100/o NaHCO,. 
The sodium hydrocarbonate solution was acidified and reextracted with ethyl 
acetate. The organic layer was evaporated to the crystalline product (56 mg, 86.90/o), 
m. p. 166-167 °c (from ethyl acetate), RF ca. 0.11. 
Anal. C19H24N205 (376.40) calc'd. : C 60.62; H 6.43; N 7.440/o 
found: C 60.81; H 6.40; N 7 .560/o 
UV spectrum: Amax 228 nm (log £ 3.95). IR spectrum: Yrnax 3389, 3348, 1751, 1749, 1703, 
1672, 1654, 1624, and 716 cm-1• NMR spectrum (DMSO-d5): -r 1.78 (lH, d, CONH; 
J 7.9 Hz), 1.92-2.25 (2H and lH, m, aromatic protons and CONH), 2.37-2.67 (3H, 
m, aromatic protons), 5.90 (2H, q , CH2; 1 Et 7.2 Hz), 6.2 (2H, d, N-CH2; J 5.5 Hz), 
8.80 (3H, t, CHa; JEt 7.2 Hz). 
b) A suspension of dicarboxylic acid (IV) (225 mg, 0.772 mmol), hydrochloride 
of glycine ethyl ester (215 mg, 1.545 mmol), and triphenylphosphine (486 mg, 1.854 
mmol), triethylamine (0.432 ml, 3.08 mmol) and carbon tetrachloride (0.155 ml, 
1.55 mmol) in acetonitrile (3 ml) was stirred for 19 h . From the NaHC03 layer 
the acidic product (VI) was extracted (70 mg, 240/o), and from ethylacetate solution 
4-benzamidocyclohexane-1,1-dicarbonylglycine diethyl ester (VII), the latter being 
purified on a silica gel column by elution with methylene chloride (103 mg 28.90/o), 
m . p.145-146 °c (from ethyl acetate), Rp ca. 0.652. 
Anal. C2aHa1Na01 (461.50) calc'd.: C 59.85; H 6.77; N 9.110/o 
found: C 59.86; H 6.50; N 9.340/o 
UV spectrum: 2rnax 228 nm (log e 4.11). IR spectrum: Ymax 3310 br, 1747, 1732, 1721, 
1658, 1643, 717, and 694 cm-1• NMR spectrum (DMSO-d6) : -r 1.61-1.98 (2H, m, 2CONH), 
2.02-2.36 (2H and lH, m, aromatic protons and CONH), 2.42-2.75 (3H, m , aromatic 
protons), 5.91 and 5.93 (each 2H, 2q, CH2; 1 Et 7.1 Hz), 6.23 (4H, d, 2N-CH2; J 5.0 Hz), 
8.82 (6H, t, 2 CH3 ; JEt 7.1 Hz) . 
4-Benzamidocyclohexane-1-carbethoxy-l-carbonylglycine Ethyl Ester (VIII) 
Cyclohexane carboxylic acid (VI) (54 mg, 0.144 mmol) was dissolved in 30/o 
ethanolic hydrochloric acid (11 ml), heated under reflux for 19 h, and then evapo-
rated to drynes. Preparative TLC separated a glassy product (43 mg, 74.090/o), RF ca. 
0.69, purified by precipitation from chloroform-n-hexane. 
Anal. C21H2sN205 (404.45) calc'd.: C 62.36; H 6.98; N 6.930/o 
found : C 62.22; H 6.69; N 6.690/o 
UV spectrum: Amax 227 nm (log Ii 4.04). IR spectrum: Ymax 3338 br, 1751 sh, 1735, 
1665 sh, 1635, 713, and 693 cm-1• NMR spectrum: -r 2.15-2.38 and 2.41-2.67 (2H and 
3H,2m, aromatic protons), 3.20-3.75 (lH, m, CONH), 4.03 (lH, d, CONH; J 7.9 Hz), 
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5.72 and 5.78 (each 2H, 2q, 2 CH2; JEt 7.2 Hz), 6.04 (2H, d, N-CH2; J 5.3 Hz), 8.70 
and 8.74 (each 3H, t, 2 CH3; JEt 7.2 Hz). 
Stereoisomeric 4-Benzamidocyclohexane-1-carboxy-1-carbonyl-L-
-phenylalanine Methyl Esters (IX A and B) 
A suspension of cyclohexane dicarboxylic acid (IV) (187 mg, 0.642 mmol), hydro-
chloride of L-phenylalanine metyl ester (277 mg, 1.284 mmol), triethylamine (0.36 
ml, 2.57 mmol), carbon tetrachloride (0.128 ml, 1.28 mmol), and triphenylphosphine 
(337 mg, 1.284 mmol) in acetonitrile (5 ml), following the procedure described for 
the preparation of the compound (VI), afforded a mixture of stereoisomers (257 mg, 
88.60/o), separated by preparative TLC (two developments) at RF ca. 0.43 and ca. 
0.39 (ratio 1.17 : 1.0). The stereoisomer A (RF ca. 0.43) was recrystallized from chloro-
form-ether-n-hexane, m. p. 115-117 oc, [a]n23 = 13.70 (c 1.1). 
Anal. C2sH2sN20a (452.49) calc'd.: C 66.36; H 6.24; N 6.190/o 
found: C 66.33; H 5.98; N 5.86°/o 
UV spectrum: Amax 215 sh and 226 sh nm (log s 3.85 and 3.80). IR spectrum 1'max 3404 
br, 1740 br, 1660 br, 1637, 756, 715, and 701 cm-1• NMR spectrum (DMSO-da): r: 1.76 
(IR, d, CONH; J 6.8 Hz), 2.10-2.24 (2H and lH, m, aromatic protons and CONH), 
2.49-2.56 (3H, m, aromatic protons) , 2.76 (5H, m , aromatic protons), 5.45-5.67 (lH, 
m , CH-Phe), 6.23 br (lH, m, H-4, obscured by those of OCH3), 6.38 (3H, s, OCH3), 
6.96 (2H, d, CHrPhe; J 6.8 Hz). 
The stei::eoisomer B (RF ca. 0.39) was recrystallized as hydrate from chloroform-
-n-hexane, m. p . 94-96 °c, [o.]n26 = -5.3° (c 1-23). 
Anal. C25H 28N20 6 • H20 (470.49) calc'd.: C 63.81; H 6.43; N 5.950/o 
found: C 64.13; H 6.56; N 5.850/o 
UV spectrum: Amax 215 sh and 225 sh nm (log s 3.87 and 3.81). IR spectrum: Vmax 
3340 br, 1745 br, 1666, 1633, 754, 714, and 701 cm-1• NMR spectrum: r: 1.36 (lH, d, CONH; 
J 6.8 Hz), 1.87 (lH, d, CONH; J 6.8 Hz), 2.11-2.24, 2.44-2.65, and 2.77 (2H, 3H, and 
5H; 2m and s; aromatic protons), 5.33-5.63 (lH, m, CH-phe), 5.69-5.94 (lH, m , H-4). 
6.43 (3H, s, OCH3), 7.03 (2H, d, CH2-phe; J 6.8 Hz). 
Stereoisomeric 4-Benzamidocyclohexane-1-carboxyl-1-carbonyl-L-
-phenylalanine Benzyl Esters (X A and B) 
A suspension of cyclohexane dicarboxylic acid (IV) (53 mg, 0.182 mmol) , L-phe-
nylalanine benzyl ester hydrochloride (106 mg, 0.364 mmol), trietylamine (0.088 ml, 
0.63 mmol), carbon tetrachloride (0.036 ml, 0.36 mmol), and triphenylphosphine (105 
mg, 0.4 mmol) in acetonitrile (3 ml) , following the above described procedure, 
afforded a mixture of stereoisomers (33 mg, 34.30/o). Crystallization from chloroform-
-ether-n-hexane yielded predominantly cis-isomer A, RF ca. 0.21. From the mother 
liquor the trans-isomer B was isolated on preparative TLC at RF ca. 0.13 (recovery 
with methanol) . The stereoisomer A (RF ca. 0.21) had m. p. 177-178 °c, [a]n23 = -25° 
(c 1). 
Anal. Ca1H32N206 (528.58) calc'd.: C 70.45; H 6.10; N 5.300/o 
found: C 70.30; H 5.83; N 5.020/o 
UV spectrum: Amax 203 and 223 sh nm (log s 4.39 and 4.11). IR spectrum: Vmax 3339, 
1745, 1733, 1667, 763, 732, and 700 cm· 1. NMR spectrum: r: -2.69 (lH,s,COOH), 1.76 
and 2.0 (2H, 2d, CONH; J 6.8 Hz), 2.01-2.21 and 2.47-2.60 (2H, and 3H, 2m, N-benzoyl 
protons), 2.65 and 2.77 (10 H, 2s, 2 phenyl protons), 4.9 br (2H, s, OCH2-ph), 5.34-5.70 
(lH, m, N-CH-CO), 6.03-6.47 (lH, m, 4-H), 6.93 (2H, d, CH2-ph; J 6.8 Hz). 
The stereoisomer B (RF ca. 0.13) showed m. p. 120-121 °c (from methanol-
-ether-n-hexane, exhibited r: - 2.6 br (lH, s, COOR), 1.82-2.01 (lH, m, 2CONH), 
2.09-2.28 and 2.43-2.61 (5H, 2m, N-benzoyl protons) 2.71 and 2.80 (10 H , 2s, 2 phenyl 
protons), 4.92 br (2H, s, OCH2-phe), 5.32-5.63 (lH, m, N-CH-CO), 6.21-6.55 (lH, 
m , 4-H), 6.94 (2H, d, CH2-ph ; J 6.6 Hz). 
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4-c-Benzamidocyclohexane-r-1-carbomethoxy-1-carbonyl-L-phenylalanine 
Methyl Ester (XI A) 
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A solution of cis-benzamidocyclohexane carboxylic acid (IX A) (75 mg, 0.166 
mmol) in 30/o methanolic hydrochloric acid (5 ml) was heated under reflux for 18 h, 
and then evaporated to dryness. The residue was dissolved in ethyl acetate, washed 
with 20/o NaHC03, 50/o citric acid, and water. The organic layer was dried and 
evaporated to a product which was purified by preparative TLC (65 mg, 840/o), 
RF ca. 0.56 (CH2Cl2-MeOH, 95 : 5), and then precipitated from methylene chloride-
.-ethev-n-hexane. 
Anal. C26H 30N20 6 (466.52) calc'd.: C 66.93; H 6.48; N 6.010/o 
found: C 67.26; H 6.68; N 6.200/o 
UV spectrum : Amax 219 sh and 228 nm (log s 4.10 and 4.04). IR spectrum: Vmax 3347 
br, 1745 sh, 1738, 1657 sh, 1640, 715, and 702 cm-1. NMR spectrum: r 2.23-2.99 (10 H, 
m, aromatic protons), 3.62 (lH, d, CONH; J 7.6 Hz), 4.03 (lH, d , HNCO; J 7.6 Hz), 
5.08-5.28 (lH, m, CH-Phe), ca. 5.84-6.22 (lH, m, H-4, partly obscured by those of 
OCH3), 6.25 and 6.30 (each 3H, 2s, 2CH30), 6.68-7.08 (2H, m , CH2-Phe) . 
4-t-Benzamidocyclohexane-r-1-carbomet hoxy-1-carbonyl-L-phenylalanine 
Methyl Ester (XI B) 
A solution of trans-benzam ido derivative (IX B) (82 mg, 0.181 mmol) in 30/o metha-
nolic hydrochlor ic acid (8 ml) was t r eated and worked up as described for isomer 
(XI A). Yield 72 mg (85.30/o), m. p. 138-139 °c (from methylene chloride-ether-n-
-hexane), RF ca. 0.56 (CH2Ch-MeOH, 95 : 5). 
Anal. C25H30N20 6 (466.52) calc'd .: C 66.93; H 6.48 ; N 6.010/o 
found : C 67.02; H 6.35 ; N 6.230/o 
UV spectrum : },max 218 sh and 226 nm (log s 4.08 and 4.01). IR spectrum: Vmax 3337, 
1738, 1732 sh, 1655, 1640, 717, and 707 cm-1. NMR spectrum: r. 2.23-2.95 (10 H, m , 
aromatic protons), 3.59 (lH, d,CONH; J 7.8 Hz), 4.06 (lH, d , NHCO; J 7.8 Hz), 
5.01-5.21 (lH, m, CH-Phe), ca. 5.84-6.20 (lH, m , H-4, partly obscured by those of 
OCH3) , 6.25 and 6.35 (each 3H, 2s, 2CHs0), 6.66-7.09 (2H, m , CH2-Phe) . 
Cyclisation of 4-c-Benzami docyclohexane-r-1-carbomethoxy-1-carbonyl-
-L-phenylalanine Methyl Ester (XI A) 
Formation of 2-N-benzoyl-2-azabicyclo[2.2.2] oct an-3-one-4-carbonyl-L-phenyla-
lanine Methyl Ester XII). The pure cis-isomer XI A (38.5 mg, 0.083 mmol) was 
heated at 250 °c (N2 atmosphere) for 1 h . The product was separated by preparative 
TLC in 27.90/o (10 mg) yield, RF ca. 0.75 (CH2Cl2-Me0H, 95 : 5). IR spectrum: 
'Vmax 3204 br, 2948, 1756, 1743, 1686 br, 1661, 753, 702, and 696 cm-1. NMR spectrum: 
r 1.3 (lH, d , NH; J 6.4 Hz), 2.3- 2.57 and 2.64-2.96 (2H and 3H, 2m, aromatic protons), 
5.01-5.34 (lH, m, 4-H and N-CH-CO), 6.33 (3H, s, OMe), 6.74-7.16 (2H, h, CH2-ph). 
4-0xocyclohexane-1-carboxy-1-carbonyl-L-phenyLalanine Methyl Ester (XIV) 
A suspension of 4-oxocyclohexane-1 ,1-dicarboxylic acid27 (XIII) (372 mg, 2 
mmol), hydrochloride of L-phenylalanine methyl ester (431 mg, 2 mmol), triphenyl-
phosphine (525 mg, 2 mmol), triethylamine (0.56 ml, 4 mmol), and carbon tetrachlo-
ride (0.4 ml, 4 mmol) in acetonitrile (7 ml) was stirred at room temperature for 
24 h. The solvent was removed under reduced pr essure and the residue partitioned 
between ethyl acetate and 100/o NaHC03. The NaHC03 layer was acidified with 
hydrochloric acid and reextracted with ethylacetate. The ethyl acetate layer was 
washed with water, dried, and evaporated to a foamy product (506 mg, 72.80/o), 
which precipitated from chloroform-n-hexane, RF ca. 0.23, [a]n22 = -11.570 (c 2.61). 
Anal. C1sH21N05 (347.36) calc'd . : C 62.24; H 6.10 ; N 4.030/o 
found: C 62.22; H 6.35; N 3.860/o 
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UV spectrum: Amax 239 nm (logs 3.35). IR spectrum: Vmax 3370 br, 1740 br, 1675 br, 
750, and 709 cm-1. NMR spectrum: r- 0.68-0.0 (lH, m, COOH), 2.72-3.50 (5H, and 
lH, m, aromatic protons and CONH), 4.90-5.42 (lH, m, CH-Phe), 6.33 (3H, s, OCH3), 
6.73-7.05 (2H, m, CH2-Phe). 
4-0xocyclohexane-1-carbomethoxy-1-carbonyl-L-phenylalanine Methyl 
Ester (XV) 
A solution of cyclohexane carboxylic acid (XIV) (289 mg, 0.858 mmol) in 3°/o 
methanolic hydrochloric acid (20 ml) was heated under reflux for 19 h and then 
evaporated to dryness. The residue was dissolved in ethyl acetate, washed with 
water, dried, and evaporated to the product (309 mg, 99.60/o), m. p . 89-90 °c (from 
chloroform-n-hexane), RF ca. 0.69, [a]D26 = -28.60 (c 1.1). 
Anal. C19H2aN06 (361.38) calc'd.: C 63.14; H 6.42; N 3.880/o 
found : C 63.12; H 6.48; N 4.160/o 
IR spectrum: Vmax 3344, 1744, 1727, 1716, 1656, 1620, 751, and 705 cm-1. NMR 
spectrum: r 2.58-3.06 (5H, aromatic protons), 3.47 (lH, d, CONH; J 7.7 Hz), 4.95-5.38 
(lH, m, CH-Phe), 6.30 and 6.33 (each 3H, 2s, 2CH30), 6.75-7.03 (2H, m, CH2-Phe). 
4-0xyiminocyclohexane-1-carb omethoxy-1-carbon y l-L-ph{:!n y lalanine 
Methyl Ester (XVI) 
To a solution of 4-oxocyclohexane (XV) (492 mg, 1.361 mmol) in ethanol (6 ml) 
hydroxylarriine hydrochloride (111 mg, 1.6 mmol) dissolved in water (2.5 ml) was 
added. The mixture was stirred and treated portionwise with Na2C03 (85 mg, 0.8 
mmol) in water (2.5 ml) during a time interval of 15 min. After 5 h water (20 ml) 
was added and extracted with ether. The extract was dried and evaporated to a 
foamy residue (483 mg, 94.20/o), which precipitated from chloroform-n-hexane, R F ca 
0.67, [a]D25 = -29.03° (c 3.1). 
Anal. C19H24N206 (376.40) calc'd.: C 60.62; H 6.43 ; N 7.440/o 
found: C 60.33; H 6.62; N 7.170/o 
IR spectrum: vmax 3384 br, 1737 br, 1664 br, 1621 br, 742 br, and 700 cm-1• NMR 
spectrum: r 2.60-3.03 (5H, m, aromatic protons), 3.50 (lH, d, CONH; J 7.8 Hz), 
4.95-5.33 (lH, m, CH-Phe), 6.28 and 6.33 (each 3H, 2s, 2CH30), 6.76-6.96 (2H, m, 
CH2-Phe). 
Stereoisomeric 4-A minocyclohexane-1-carbomethoxy-1-carb ony l-L-
-cyclohexy lalanine Methyl Esters (XVII) 
A solution of 4-oxyiminocyclohexane (XVI) (367 mg, 0.975 mmol) in glacial 
acetic acid (36 ml) was hydrogenated at room temperature and 0.34 MPa for 29 h 
over 50/o Rh/Ah03 (283 mg). The catalyst was filtered off and the filtrate evaporated 
to dryness. The residue was dissolved in dilute ammonia and extracted with ethyl 
acetate. From the ethyl acetate layer the product separated (204 mg, 56.70/o), which 
precipitated from chloroform-ether-n-hexane as a foam, RF ca. 0.1, [aJD25 = -26.1° 
(c 0.69). · 
Anal. C19Ha2N20s (368.46) calc'd.: C 61.93; H 8.75; N 7.600/o 
found: C 61.77 ; H 8.67; N 7.830/o 
IR spectrum: Vmax 3364, 1749 br, 1683 br, and 1650 br cm-1• NMR spectrum: r 3.70 
(lH, d, CONH; J 7.9 Hz), 5.17- 5.67 (lH, m, CH-Cha), 5.72 to region of OCH3 (lH, m, 
H-4), 6.30 (6H, s, 2CHa0). 
Stereoisomeric 4-Benzamidocyclohexane-1-carbomethoxy-1-carbonyl-L-
-cyclohexylalanine Methyl Esters (XVIII) 
To a solution of 4-aminocyclohexane (XVII) (70 mg, 0.19 mmol) in pyridine 
(5 ml) benzoic anhydride (52 mg, 0.23 mmol) was added and the mixture stirred at 
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room temperature for 16 h. The residue obtained from ethylacetate extract was 
purified by preparative TLC to a foamy product (54 mg, 60.20/o), RF ca. 0.73, pre-
cipitated from ether-n-hexane, [a]D27 = -20.5'° (c 2). 
Anal. C26HasN20s (472.56) calc'd.: C 66.08; H 7.68; N 5.930/o 
found: C 66.08; H 7.60; N 5.950/o 
UV spectrum: Amax 223 nm (log s 4.16). IR spectrum: Ymax 3334, 1742, 1658, 1651, 1640, 
718, and 698 cm-1. NMR spectrum: -r 2.18-2.45 and 2.48-2.70 (2H and 3H, 2m, 
aromatic protons), 3.63 and 3.86 (each lH, 2d, J 8.0 and 8.0 Hz), 5.18-5.68 (lH, m, 
CH-Cha), 5.69 to region of OCH3 (lH, m , H-4), 6.17, 6.28, and 6.32 (6H, 3s, 2CHs0). 
Stereoisomeric 4-N-(N-t-Butoxycarbonyl-0-benzyl-L-tyrosyl) 
4-aminocyclohexane-1-carbomethoxy-1-carbonyl-L-cyclohexylalanine 
Methyl Esters (XIX) 
To a solution of N-hydroxysuccinimide ester of N-t-butoxycarbonyl-O-benzyl-
-L-tyrosine31 (211 mg, 0.451 mmol) in 1,2-dimethoxyethane (5 ml) 4-aminocyclohexane 
(XVII) (166 mg, 0.451 mmol) was added and stirred at room temperature for 19 h. 
The solvent was removed under reduced pressure and the residue dissolved in ethyl 
acetate, washed with 50/o citric acid, 0.2 mol dm-3 NaHC03, and water to be evapo-
rated to dryness and purified by preparative TLC, RF ca. 0.66. The product (110 mg, 
33.80/o) was precipitated from chloroform-ether-n-hexane, [a]n25 = -5.30 (c · 2). 
Anal. C40H5sN309 (721.86) calc'd.: C 66.55; H 7.68; N 5.820/o 
found: C 66.79; H 7.74; N 5.930/o 
UV spectrum: J.max 228 nm (log c 4.00). IR spectrum: Ymax 3330 br, 1736, 1731 sh, 
1651 br, 735, and 695 cm-1. NMR spectrum: r 2.68 (5H, s, aromatic protons), 2.83-3.35 
(4H, m, Tyr-aromatic protons), 3.36 (lH, d, CONH; J 8.1 Hz), 4.98 (lH, d, CONH; J 
7.9 Hz), 5.02 (2H, s, OCH2), 6.34 (6H, s, 2CHa0), 7.10 (2H, d, CH2-Tyr; J 6.0 Hz), 
8.61 (9H, s, C(CHs)3). 
Stereoisomeric 4-Hydroxycyclohexane-1-carboxy-1-carbonyl-L-
-cyclohexylalanine Methyl Esters (XX) 
A solution of 4-oxocyclohexane-1-carboxyl-1-carbonyl-L-phenylalanine methyl 
ester (XIV) (l.795 mg, 5.168 mmol) in glacial acetic acid (60 ml) containing Pt02 
(359 mg) was stirred in hydrogen atmosphere under 0.34 MPa for 40 h. The catalyst 
was filtered off and the filtrate evaporated to an unseparable foam (1.7 g, 92.60/o), 
RF ca. 0.25, used for further experiments. 
Stereoisomeric 4-Hydroxycyclohexane-1-carbomethoxy-1-carbonyl-L-
-cyclohexylalanine Methyl Esters (XXI) 
A solution of 4-oxocyclohexane-1-carbomethoxyl-1-carbonyl-L-phenylalanine 
methyl ester (XV) (389 mg, 1.076 mmol) in glacial acetic acid (15 ml) containing 
Pt02 (76 mg) was hydrogenated as described above. The product (368 mg, 92.60/o), as 
a foamy mixture of stereoisomers, was purified by preparative TLC, RF ca. 0.6, and 
used for further experiments. 
Stereoisomeric 4-Hydroxycyclohexane-1-carbomethoxy-1-carbonyl-L-
-phenylalanine Methyl Esters (XXII) 
To a solution of 4-oxocyclohexane derivative (XV) (275 mg, 0.761 mmol) in 
anhydrous methanol (5 ml) sodium borohydride (29 mg, 0.761 mmol) was added 
and the mixture set aside for 15 min. Acetone (6 ml) was then added and the 
solvents removed at the reduced pressure. The residue was dissolved in ethylacetate, 
washed with water, dried, and then evaporated to an oily product (240 mg, 86.70/o), 
distilled at 130 °c and 10-2 mmHg, Rr' ca. 0.58, [a]n27 = -12.21° (c 2.3). 
Anal. C19H2sNOa (363.40) calc'd.: C 62.79; H 6.93; N 3.850/o 
found: C 62.50; H 6.95; N 4.110/o 
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UV spectrum: J. 111"" 238 nm (log E 3.30) . IR spectrum: 1' max 3410 br, 1738, 1664, 1640, 
718, and 706 cm-1. NMR spectrum: r 2.64-3.13 (5H, m, aromatic protons), 3.62 (lH, d , 
CONH; J 8.0 Hz), 5.00-5.50 (lH, m, CH-Phe), 6.33, 6.43, and 6.47 (6H, 3s, 2CHs0) , to 
6.79 (lH, m, H-4, obscured by those of OCH~). 6.80-7.10 (2H, m, CH2-Phe) , 7.47 (lH, 
s,OH). 
4-c- (XXIII A) and 4-t- (XXIII B) Benzoxycyclohexane-r-1-carbomethoxy-
-1-carbomethoxy-1-carbonyl-L-cyclohexylalanine Methyl Esters 
To a solution of a mixture of stereoisomeric 4- hydroxycyclohexane- 1-carbo-
methoxy derivatives (XXI) (440 mg, 1.19 mmol) in anhydrous pyridine (30 ml) benzoyl 
chloride (0.16 ml, 1.39 mmol) was added and stirred at room temperature for 20 h. 
The solvent was removed under reduced pressure and a mixture of stereoisomers 
separated by preparative TLC (ether-n-hexane, 1 : 1). The foamy cis-isomer A 
(RF ca. 0.24), [a ]D24 = - 21.2~ (c 2.1) was separated in 47.90/o (270 mg) yield. 
Anal. C26Hs5NO; (473.55) calc'd.: C 65.94; H 7.45; N 2.960/o 
found: C 66.16; H 7.74; N 3.030/o 
UV spectrum: Amax 229.5 nm (log E 4.11). IR spectrum: Ymax 3376 br, 1740, 1719, 1715 sh, 
1678 br, 753, and 684 cm-1• NMR spectrum: r 1.82-2.13 and 2.32-2.69 (2H and 3H, 2m, 
aromatic protons) , 3.71 (l H , d , CONH; J 8.1 Hz). 4.79-5.14 (lH, m; H - 4), 5.27·-5.49 
(lH, m, CH-Cha), 6.18 and 6.27 (each 3H, 2s, 2CH30). 
The trans-isomer B (RF ca. 0.21), m . p. 87.5-88.5 °c (from ether-n-hexane) , 
[a]D23 = - 2?.60 (c 2.1) was separ ated in 28.40/o (160 mg) yield. 
Anal. C26H 35NO; (473.55) calc'd.: C 65.94; H 7.45; N 2.960/o 
found: C 66.21; H 7.73; N 3.180/o 
UV spectrum: Xmax 230 nm (log E 4.08). IR spectrum: 1'max 3353, 1745, 1738, 1712, 1641 
br, 748, 717, and 691 cm-1• NMR spectrum: r 1.80-2.10 and 2.40-2.70 (2H and 3H, 
2m, aromatic protons), 3.69 (lH, d, CONH; J 8.1 Hz), 4.69-5.02 (lH, m, H - 4), 5.23-5.46 
(lH, m, CH-Cha), 6.20 and 6.27 (each 3H, 2s, 2CH30). 
2-0xabicyclo[2.2.2]octan-3-one-4-carbonyl-L-cyclohexylalanine Methyl 
Ester (XXIV) 
A mixture of stereoisomeric 4-oxocyclohexane- 1-carboxyl- l-carbonyl-L-cyclo-
hexylalanine methyl ester (XX) (202 m g, 0.569 mmol) and p - toluenesuplhonic acid 
(37 mg, 0.215 mmol) were suspended in anh ydrous benzene (5 ml) and heated under 
reflux for 4 h and left at room temperature for additional 1 h. The solvent was 
removed, and the residue dissolved in ethyl acetate, washed with 100/o NaHC03 water, 
dried, and evaporated to dryness. Preparative TLC separated an oily product (80 mg, 
41.80/o), RF ca. 0.81 (CH2Cb- MeOH, 95 : 5), distilled at 135-140 °c and 4.0 P a [a]D25 = 
= -13.5° (c 1.52). 
Anal. C!8H 27N05 (337.90) calc'd.: C 64.07; H 8.06; N 4.150/o 
found : C 64.23; H 8.30; N 4.030/o 
IR spectrum (EtOH): vm,,,x 3430, 2920 br, 1754, 1722, 1691 sh, and 1681 cm-1. NMH. 
spectrum: r 1.22 (lH, d, CONH-; J 7.8 H z), 5.20 br (lH, s, H-1), 5.29-5.51 (lH, m, 
CH-Cha), 6.28 (3H, s, OCHs). 
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AnaL C19H31N06 (369.45) calc 'd. : C 61.76 ; H 8.46; N 3.79°/o 
found: C 61.78; H 8.57; N 3.65°/o 
IR spectrum: },max 3474, 2924, 1746, 1737, 1732, 1718, and 1641 cm-1. NMR spectrum: 
r 3.69 (lH, d , CONH ; J 8.1 Hz) , 5.31-5.53 (lH, m , CH-Cha), 6.21 and 6.29 (each 3H, 2s, 
2CH30), 7.68 b r (lH, s, OH, disappearing in D20). 
4-c-BenzoxycycLohexane-r-1-carbomethoxy-1-carbony L-L-cycLohex y La La n ine 
MethyL Ester (XXIII A) 
A solution of 4-c-hydroxycyclohexane-r-1-car bomethoxy dipeptide (XXII A) 
(45 mg, 0.122 mmol) in anhydrous pyridine (1 ml) treated w ith the equimolar 
amount of benzoylchloride and was stirred at room temperature for 17 h . The 
solvent w as removed under reduced pressure and the residue separated on a pre-
parative TLC. It afforded a foamy product (48 mg, 83.20/o), RF ca . 0.24 (ether-n-
-hex ane, 1 : 1) , identical IR, UV, and NMR spectra) with the product obtained from 
the benzoylation of 4-hydroxycyclohexa ne derivative XXL 
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SAZETAK 
Peptidi 4-amino·- 4-hidroksicikloheksan-1,1-dikarboksilnih kiselina 
V. Skaric i J. Makarevic 
4-Amino, 4-okso- i 4-hidroksicikloheksan-1,1-dikarboksilne kiseline su ugra-
·dene u di- i tri-peptide koji sadrze glicin, L-fenilalanin, L-cikloheksilalanin i L-tiro-
zin. Geometrije 4-c- (IX A) i 4-t- (IX B) benzamidocikloheksan-r-1-karboksi-1-kar-
bonil-L-fenilalanin metil estera i 4-c- (XXIII A) i 4-t- (XXIII B) benzoksiciklohek-
san-r-1-karbometoksi-1-karbonil-L-cikloheksilalanin metil estera su potvrdene NMR 
spektrima i intramolekularnim ciklizacijama cis-izomera. Otvaranje prstena 2-oksa-
biciklo[2.2.2]oktan-3-on-4-karbonil-L-cikloheksilalanin metil estera (XXIV) u meta-
nolnoj klorovodienoj kiselini daje 4-c-hidroksicikloheksan-r-1-karbometoksi-1-karbo-
nil-L-cikloheksilalanin metil ester (XXI A) koji benzoiliranjem ,prelazi u produkt 
identican izomeru (XXIII A). 
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